English
|
Español
English
|
Español
Insurance
Marketing
Pharmaceuticals
Technology/Innovation
Regulatory
Community
University of Pittsburgh Medical Center
+
Technology/Innovation
Patient Daily Report
| Apr 12, 2023
Reach Neuro, Inc., study participant on the Avantis platform: 'This will change the lives of millions of people'
+
Community
Bree Gonzales
| Jun 9, 2021
University of Pittsburgh opens AI platform for cancer patients: 'Patients aren't defined by their primary diagnosis'
Trending
+
Pharmaceuticals
Patient Daily
| Aug 6, 2026
FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+
Pharmaceuticals
Patient Daily
| Aug 4, 2026
Merck reports mixed results for tulisokibart in recent clinical trials and financial update
+
Regulatory
M. Y. Bailey
| Aug 7, 2026
PhRMA's Zirkelbach: 340B program has changed dramatically with 'little transparency into how patients benefit'
Patient Daily reports
| Aug 10, 2026
SoCal Breathe Free warns persistent sinus symptoms may signal chronic inflammation